Brendan Pharma Private Limited
About Brendan Pharma Private Limited
Data last updated:
Brendan Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 15 July 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74999DL2014PTC268906.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Brij Mohan Tyagi and Saini Jitender.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Kh. No – 539 Ground Floor Dashrath Tyagi Market Opposite Shalimar, Palace, New Delhi, Delhi, India – 110084.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.25 Lakh, a growth of 3% compared to the previous year. For the same year it recorded a net loss of ₹3,230 (net margin -2.6%) and EBITDA of -₹3,230 (EBITDA margin -2.6%). Revenue has declined at a compounded annual rate (CAGR) of 2% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Brendan Pharma Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressKh. No – 539 Ground Floor Dashrath Tyagi Market Opposite Shalimar, Palace, New Delhi, Delhi, India – 110084
- IndustryTrading, Other Wholesale, Wholesale
To see the full contact details of Brendan Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Brendan Pharma is manufacturing. In detail, this covers manufacture of chemicals and chemical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 20 | Manufacture of chemicals and chemical products |
To see the full business activity and turnover split of Brendan Pharma Private Limited, buy the company report.
Financials of Brendan Pharma Private Limited
FY 2025 filings availableBrendan Pharma Private Limited reported revenue of ₹1.25 Lakh (up 3% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 3% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 2%. EBITDA rose 69% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹3,230 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹3,230 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -2.6% | ||||
| Net Profit Margin | -2.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Brendan Pharma Private Limited, buy the company report.
Board of directors of Brendan Pharma Private Limited
Brendan Pharma has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Brij Mohan Tyagi | Director | 08 Jun 2019 | 7 Years 4 Months | Current |
| Saini Jitender Also directs: Biocoll Pharmaceuticals Private Limited | Director | 01 Jun 2019 | 7 Years 4 Months | Current |
Peer comparison
Brendan Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (manufacture of chemicals and chemical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| B.B.Chemicals Private Limited | ₹1.42 Lakh (FY 2025) | 12.0% | Karnataka, India | |||
| Shiv Specialties Private Limited | ₹1.4 Lakh (FY 2025) | Raigar, Maharashtra, India | ||||
| Q-Line Nutraceuticals Private Limited | ₹1.38 Lakh (FY 2025) | Lucknow, Uttar Pradesh, India | ||||
| Yr&J Health Care Private Limited | ₹1.34 Lakh (FY 2024) | Delhi, India | ||||
| Utkrsta Essentials Private Limited | ₹1.27 Lakh (FY 2025) | Ranchi, Jharkhand, India | ||||
| Brendan Pharma Private Limitedthis company | ₹1.25 Lakh (FY 2025) | -₹3,230 | -2.6% | 3.0% | New Delhi, Delhi, India | |
| Rutab Healthcare Private Limited | ₹1.25 Lakh (FY 2024) | Bhopal, Madhya Pradesh, India | ||||
| Sanprem Industries Private Limited | ₹1.25 Lakh (FY 2025) | Pune, Maharashtra, India | ||||
| Bioveet Pharmaceuticals Private Limited | ₹1.23 Lakh (FY 2025) | Pune, Maharashtra, India | ||||
| Labsign India Private Limited | ₹1.2 Lakh (FY 2025) | Hyderabad, Telangana, India | ||||
| Ananyaa Crop Science Private Limited | ₹1.19 Lakh (FY 2025) | Sinnar, Maharashtra, India |
To see the full peer comparison of Brendan Pharma Private Limited, buy the company report.
Auditor
Brendan Pharma Private Limited is audited by RAJIV BHUSHAN & CO. for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RAJIV BHUSHAN & CO. | FY 2017 | 005721C |
Shareholding
The shareholding of Brendan Pharma Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Brendan Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Brendan Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Brendan Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Brendan Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Brendan Pharma Private Limited has 6 board changes on record since 2019: 2 appointments and 4 cessations. The latest: Brij Mohan Tyagi ceased to be Additional Director on 30 Sep 2019.
Frequently asked questions
Brendan Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in other wholesale, within the trading industry. It was incorporated on 15 July 2014 (12+ years old) and is registered under CIN U74999DL2014PTC268906.
Brendan Pharma has 2 current directors:
- Brij Mohan Tyagi - Director
- Saini Jitender - Director
The latest financial statements of Brendan Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Brendan Pharma is U74999DL2014PTC268906. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Brendan Pharma was incorporated on 15 July 2014, making it 12+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Brendan Pharma by revenue are B.B.Chemicals Private Limited, Shiv Specialties Private Limited, Q-Line Nutraceuticals Private Limited, Yr&J Health Care Private Limited, Utkrsta Essentials Private Limited and 5 more, all in the same principal business activity (manufacture of chemicals and chemical products).
Brij Mohan Tyagi ceased to be Additional Director on 30 Sep 2019. Saini Jitender ceased to be Additional Director on 30 Sep 2019. Brij Mohan Tyagi was appointed as Director on 08 Jun 2019. Brendan Pharma has 6 board changes on record in total.
The registered office of Brendan Pharma is at Kh. No – 539 Ground Floor Dashrath Tyagi Market Opposite Shalimar, Palace, New Delhi, Delhi, India – 110084.
Brendan Pharma operates in the trading industry, in the other wholesale segment.
The compliance status of Brendan Pharma is compliant as of 02 July 2026. The company is actively filing with the Registrar of Companies.
Brendan Pharma can be reached at its registered office: Kh. No – 539 Ground Floor Dashrath Tyagi Market Opposite Shalimar, Palace, New Delhi, Delhi, India – 110084.